Onconetix (BWV) Stock Forecast, Price Target & Predictions
BWV Stock Forecast
Onconetix stock forecast is as follows: an average price target of $4.00 (represents a 2205.48% upside from BWV’s last price of $0.17) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
BWV Price Target
The average price target for Onconetix (BWV) is $4.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $4.00 to $4.00. This represents a potential 2205.48% upside from BWV's last price of $0.17.
BWV Analyst Ratings
According to 1 Wall Street analysts, Onconetix's rating consensus is 'Buy'. The analyst rating breakdown for BWV stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Onconetix Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Dec 08, 2022 | - | Maxim Group | $4.00 | $1.20 | 233.33% | 2205.48% |
The latest Onconetix stock forecast, released on Dec 08, 2022 by Maxim Group company, set a price target of $4.00, which represents a 233.33% increase from the stock price at the time of the forecast ($1.20), and a 2205.48% increase from BWV last price ($0.17).
Onconetix Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $0.17 | $0.17 | $0.17 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Onconetix stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Onconetix's last price of $0.17. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 08, 2022 | Maxim Group | - | Buy | Initialise |
Onconetix's last stock rating was published by Maxim Group on Dec 08, 2022. The company Initialise its BWV rating from "null" to "Buy".
Onconetix Financial Forecast
Onconetix Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Avg Forecast | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - |
| # Analysts | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - |
Onconetix's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. BWV's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Onconetix EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - |
| EBITDA | - | - | - | - | $-4.49M | $-3.15M |
| Avg Forecast | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - |
undefined analysts predict BWV's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Onconetix's previous annual EBITDA (undefined) of $NaN.
Onconetix Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - |
| Net Income | - | - | - | - | $-5.35M | $-6.87M |
| Avg Forecast | $24.45M | $21.29M | $-1.75M | $-1.75M | $-1.43M | $18.97M |
| High Forecast | $19.93M | $17.35M | $-1.43M | $-1.75M | $-1.43M | $15.45M |
| Low Forecast | $28.98M | $25.23M | $-2.07M | $-1.75M | $-1.43M | $22.48M |
| Surprise % | - | - | - | - | 3.73% | -0.36% |
Onconetix's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. BWV's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Onconetix SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - |
| SG&A | - | - | - | - | $4.27M | $2.30M |
| Avg Forecast | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - |
Onconetix's average Quarter SG&A projection for Dec 23 is -, based on 0 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to BWV last annual SG&A of $4.27M (Sep 23).
Onconetix EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - |
| EPS | - | - | - | - | $-0.31 | $-0.43 |
| Avg Forecast | $1.54 | $1.34 | $-0.11 | $-0.11 | $-0.09 | $1.19 |
| High Forecast | $1.25 | $1.09 | $-0.09 | $-0.11 | $-0.09 | $0.97 |
| Low Forecast | $1.82 | $1.59 | $-0.13 | $-0.11 | $-0.09 | $1.41 |
| Surprise % | - | - | - | - | 3.44% | -0.36% |
According to undefined Wall Street analysts, Onconetix's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to BWV previous annual EPS of $NaN (undefined).
BWV Forecast FAQ
Is Onconetix a good buy?
Yes, according to 1 Wall Street analysts, Onconetix (BWV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of BWV's total ratings.
What is BWV's price target?
Onconetix (BWV) average price target is $4 with a range of $4 to $4, implying a 2205.48% from its last price of $0.173. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Onconetix stock go up soon?
According to Wall Street analysts' prediction for BWV stock, the company can go up by 2205.48% (from the last price of $0.173 to the average price target of $4), up by 2205.48% based on the highest stock price target, and up by 2205.48% based on the lowest stock price target.
Can Onconetix stock reach $0?
BWV's average twelve months analyst stock price target of $4 supports the claim that Onconetix can reach $0 in the near future.
What are Onconetix's analysts' financial forecasts?
BWV's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $15.78M (high $12.27M, low $19.3M), average SG&A $0 (high $0, low $0), and average EPS is $0.992 (high $0.772, low $1.21).